The surgical sealants and tissue patches market size has grown strongly in recent years. It will grow from $2.56 billion in 2025 to $2.82 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to increasing volume of surgical procedures, rising prevalence of cardiovascular and orthopedic disorders, wider acceptance of sealants over sutures, expansion of hospital surgical infrastructure, availability of advanced biomaterials.
The surgical sealants and tissue patches market size is expected to see strong growth in the next few years. It will grow to $4.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, rising focus on reducing post-operative complications, expansion of regenerative medicine applications, growing investments in advanced surgical biomaterials, increasing adoption across specialty surgeries. Major trends in the forecast period include increasing adoption of bioengineered sealants, rising use of synthetic and hybrid adhesives, growing demand for minimally invasive surgical solutions, expansion of advanced hemostatic technologies, enhanced focus on faster wound healing outcomes.
The increasing number of accidents and sports-related injuries is expected to significantly drive the growth of the surgical sealants and tissue patches market. Accidents and sports injuries result from physical harm caused by unforeseen incidents, falls, or excessive strain during activities such as sports. With a growing number of people participating in high-impact sports and outdoor activities, the risk of traumatic injuries is rising. Surgical sealants and tissue patches play a vital role in enhancing the treatment of such injuries by providing quick and effective wound closure, reducing recovery times, and minimizing the risk of infection. These products improve patient outcomes by offering minimally invasive solutions that promote faster healing and reduce the need for traditional stitches. For example, in March 2025, the Department of Infrastructure, Transport, Regional Development, Communication, and the Arts, an Australia-based government agency, reported 1,292 road fatalities in the 12 months ending February 2025, reflecting a 1.6% increase compared to the previous year. Additionally, in 2023, the National Safety Council in the U.S. noted a 2% increase in sports and recreational injuries, continuing a trend of rising injury rates from the previous years. As a result, the growing incidence of accidents and sports-related injuries is significantly driving the demand for surgical sealants and tissue patches.
To address the growing need for advanced solutions in treating injuries, major companies in the surgical sealants and tissue patches market are focusing on developing innovative products, such as absorbable polyethylene glycol (PEG) hydrogel, which enhances surgical outcomes. This technology provides rapid, watertight sealing, reduces complications, and improves patient recovery, particularly in spinal and dural repair procedures. PEG hydrogel is a biocompatible, synthetic polymer that forms a temporary watertight seal over tissues, which is naturally absorbed by the body over time. For instance, in March 2025, Pramand LLC, a U.S.-based medical device company, launched the SpineSeal spine sealant system following FDA premarket approval. SpineSeal is a PEG hydrogel designed to provide a watertight seal over sutured dural repairs during spinal surgery, preventing cerebrospinal fluid (CSF) leakage. The sealant is applied over sutures using a specialized applicator and forms a watertight seal within seconds, enhancing recovery outcomes in patients undergoing spinal surgery.
In June 2023, H.B. Fuller Company, a U.S.-based adhesives manufacturing company, acquired Adhezion Biomedical LLC for $95.8 million. This acquisition enabled H.B. Fuller to expand its healthcare and medical adhesives portfolio, especially in the surgical adhesives and wound care markets. Through this strategic move, H.B. Fuller strengthened its position in the medical adhesives market, gaining access to Adhezion's advanced cyanoacrylate products, which are widely used in various clinical applications, including surgical sealants and tissue patches. Adhezion Biomedical LLC is a U.S.-based medical device company that specializes in surgical adhesives, sealants, and tissue patches.
Major companies operating in the surgical sealants and tissue patches market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Baxter International Inc., Terumo Corporation, Integra LifeSciences Holdings Corporation, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Ocular Therapeutix Inc., Arch Therapeutics Inc., RUA Life Sciences plc, GEM S.r.l., Tissx GmbH, Cohera Medical Inc., CryoLife Inc., Vivostat A/S, Corza Medical, Hemostasis LLC, Surgical Specialties Corporation.
North America was the largest region in the surgical sealants and tissue patches market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical sealants and tissue patches market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical sealants and tissue patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the surgical sealants and tissue patches market by increasing costs of imported biomaterials, polymers, biological reagents, and specialized manufacturing equipment used in sealant and patch production. Hospitals and device manufacturers in North America and Europe are most affected due to reliance on globally sourced raw materials, while Asia-Pacific faces pricing pressure on export-oriented production. These tariffs are increasing procurement costs and affecting pricing strategies. However, they are also encouraging localized manufacturing, regional sourcing of biomaterials, and increased investment in domestic medical device production capabilities.
The surgical sealants and tissue patches market research report is one of a series of new reports that provides surgical sealants and tissue patches market statistics, including surgical sealants and tissue patches industry global market size, regional shares, competitors with a surgical sealants and tissue patches market share, detailed surgical sealants and tissue patches market segments, market trends and opportunities, and any further data you may need to thrive in the surgical sealants and tissue patches industry. This surgical sealants and tissue patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Surgical sealants and tissue patches are medical devices designed to control bleeding, seal tissues, and promote healing during surgeries. Sealants are bioadhesive materials that bond tissues together, preventing leaks of fluids or air, while tissue patches provide structural support to aid in tissue regeneration. These products are commonly used in cardiovascular, orthopedic, and general surgeries to improve recovery and reduce complications.
The key product types in the surgical sealants and tissue patches market include natural and biological sealants, synthetic and polymer-based sealants, and hybrid sealants. Natural and biological sealants are biocompatible materials derived from natural sources, used in surgical procedures to achieve tissue adhesion, hemostasis, and wound closure. The primary indications for these products include surgical hemostasis, tissue sealing, tissue engineering, and wound closure. They are used in a variety of surgeries, including cardiovascular, neurological, orthopedic, general, urological, and pulmonary procedures. The main end users of these products are hospitals, ambulatory surgical centers (ASCs), and specialty clinics.
The surgical sealants and tissue patches market consists of revenues earned by entities by providing services such as wound closure, leak prevention, hemostasis management, tissue adhesion, reinforcement of surgical repairs and postoperative healing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The surgical sealants and tissue patches market also includes sales of hemostatic agents, collagen-based patches, protein-based adhesives and bioresorbable patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The surgical sealants and tissue patches market size is expected to see strong growth in the next few years. It will grow to $4.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, rising focus on reducing post-operative complications, expansion of regenerative medicine applications, growing investments in advanced surgical biomaterials, increasing adoption across specialty surgeries. Major trends in the forecast period include increasing adoption of bioengineered sealants, rising use of synthetic and hybrid adhesives, growing demand for minimally invasive surgical solutions, expansion of advanced hemostatic technologies, enhanced focus on faster wound healing outcomes.
The increasing number of accidents and sports-related injuries is expected to significantly drive the growth of the surgical sealants and tissue patches market. Accidents and sports injuries result from physical harm caused by unforeseen incidents, falls, or excessive strain during activities such as sports. With a growing number of people participating in high-impact sports and outdoor activities, the risk of traumatic injuries is rising. Surgical sealants and tissue patches play a vital role in enhancing the treatment of such injuries by providing quick and effective wound closure, reducing recovery times, and minimizing the risk of infection. These products improve patient outcomes by offering minimally invasive solutions that promote faster healing and reduce the need for traditional stitches. For example, in March 2025, the Department of Infrastructure, Transport, Regional Development, Communication, and the Arts, an Australia-based government agency, reported 1,292 road fatalities in the 12 months ending February 2025, reflecting a 1.6% increase compared to the previous year. Additionally, in 2023, the National Safety Council in the U.S. noted a 2% increase in sports and recreational injuries, continuing a trend of rising injury rates from the previous years. As a result, the growing incidence of accidents and sports-related injuries is significantly driving the demand for surgical sealants and tissue patches.
To address the growing need for advanced solutions in treating injuries, major companies in the surgical sealants and tissue patches market are focusing on developing innovative products, such as absorbable polyethylene glycol (PEG) hydrogel, which enhances surgical outcomes. This technology provides rapid, watertight sealing, reduces complications, and improves patient recovery, particularly in spinal and dural repair procedures. PEG hydrogel is a biocompatible, synthetic polymer that forms a temporary watertight seal over tissues, which is naturally absorbed by the body over time. For instance, in March 2025, Pramand LLC, a U.S.-based medical device company, launched the SpineSeal spine sealant system following FDA premarket approval. SpineSeal is a PEG hydrogel designed to provide a watertight seal over sutured dural repairs during spinal surgery, preventing cerebrospinal fluid (CSF) leakage. The sealant is applied over sutures using a specialized applicator and forms a watertight seal within seconds, enhancing recovery outcomes in patients undergoing spinal surgery.
In June 2023, H.B. Fuller Company, a U.S.-based adhesives manufacturing company, acquired Adhezion Biomedical LLC for $95.8 million. This acquisition enabled H.B. Fuller to expand its healthcare and medical adhesives portfolio, especially in the surgical adhesives and wound care markets. Through this strategic move, H.B. Fuller strengthened its position in the medical adhesives market, gaining access to Adhezion's advanced cyanoacrylate products, which are widely used in various clinical applications, including surgical sealants and tissue patches. Adhezion Biomedical LLC is a U.S.-based medical device company that specializes in surgical adhesives, sealants, and tissue patches.
Major companies operating in the surgical sealants and tissue patches market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Baxter International Inc., Terumo Corporation, Integra LifeSciences Holdings Corporation, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group plc, Ocular Therapeutix Inc., Arch Therapeutics Inc., RUA Life Sciences plc, GEM S.r.l., Tissx GmbH, Cohera Medical Inc., CryoLife Inc., Vivostat A/S, Corza Medical, Hemostasis LLC, Surgical Specialties Corporation.
North America was the largest region in the surgical sealants and tissue patches market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical sealants and tissue patches market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical sealants and tissue patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the surgical sealants and tissue patches market by increasing costs of imported biomaterials, polymers, biological reagents, and specialized manufacturing equipment used in sealant and patch production. Hospitals and device manufacturers in North America and Europe are most affected due to reliance on globally sourced raw materials, while Asia-Pacific faces pricing pressure on export-oriented production. These tariffs are increasing procurement costs and affecting pricing strategies. However, they are also encouraging localized manufacturing, regional sourcing of biomaterials, and increased investment in domestic medical device production capabilities.
The surgical sealants and tissue patches market research report is one of a series of new reports that provides surgical sealants and tissue patches market statistics, including surgical sealants and tissue patches industry global market size, regional shares, competitors with a surgical sealants and tissue patches market share, detailed surgical sealants and tissue patches market segments, market trends and opportunities, and any further data you may need to thrive in the surgical sealants and tissue patches industry. This surgical sealants and tissue patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Surgical sealants and tissue patches are medical devices designed to control bleeding, seal tissues, and promote healing during surgeries. Sealants are bioadhesive materials that bond tissues together, preventing leaks of fluids or air, while tissue patches provide structural support to aid in tissue regeneration. These products are commonly used in cardiovascular, orthopedic, and general surgeries to improve recovery and reduce complications.
The key product types in the surgical sealants and tissue patches market include natural and biological sealants, synthetic and polymer-based sealants, and hybrid sealants. Natural and biological sealants are biocompatible materials derived from natural sources, used in surgical procedures to achieve tissue adhesion, hemostasis, and wound closure. The primary indications for these products include surgical hemostasis, tissue sealing, tissue engineering, and wound closure. They are used in a variety of surgeries, including cardiovascular, neurological, orthopedic, general, urological, and pulmonary procedures. The main end users of these products are hospitals, ambulatory surgical centers (ASCs), and specialty clinics.
The surgical sealants and tissue patches market consists of revenues earned by entities by providing services such as wound closure, leak prevention, hemostasis management, tissue adhesion, reinforcement of surgical repairs and postoperative healing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The surgical sealants and tissue patches market also includes sales of hemostatic agents, collagen-based patches, protein-based adhesives and bioresorbable patches. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Surgical Sealants and Tissue Patches Market Characteristics
3. Surgical Sealants and Tissue Patches Market Supply Chain Analysis
4. Global Surgical Sealants and Tissue Patches Market Trends and Strategies
5. Surgical Sealants and Tissue Patches Market Analysis of End Use Industries
7. Global Surgical Sealants and Tissue Patches Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Surgical Sealants and Tissue Patches Total Addressable Market (TAM) Analysis for the Market
9. Surgical Sealants and Tissue Patches Market Segmentation
10. Surgical Sealants and Tissue Patches Market Regional and Country Analysis
11. Asia-Pacific Surgical Sealants and Tissue Patches Market
12. China Surgical Sealants and Tissue Patches Market
13. India Surgical Sealants and Tissue Patches Market
14. Japan Surgical Sealants and Tissue Patches Market
15. Australia Surgical Sealants and Tissue Patches Market
16. Indonesia Surgical Sealants and Tissue Patches Market
17. South Korea Surgical Sealants and Tissue Patches Market
18. Taiwan Surgical Sealants and Tissue Patches Market
19. South East Asia Surgical Sealants and Tissue Patches Market
20. Western Europe Surgical Sealants and Tissue Patches Market
21. UK Surgical Sealants and Tissue Patches Market
22. Germany Surgical Sealants and Tissue Patches Market
23. France Surgical Sealants and Tissue Patches Market
24. Italy Surgical Sealants and Tissue Patches Market
25. Spain Surgical Sealants and Tissue Patches Market
26. Eastern Europe Surgical Sealants and Tissue Patches Market
27. Russia Surgical Sealants and Tissue Patches Market
28. North America Surgical Sealants and Tissue Patches Market
29. USA Surgical Sealants and Tissue Patches Market
30. Canada Surgical Sealants and Tissue Patches Market
31. South America Surgical Sealants and Tissue Patches Market
32. Brazil Surgical Sealants and Tissue Patches Market
33. Middle East Surgical Sealants and Tissue Patches Market
34. Africa Surgical Sealants and Tissue Patches Market
36. Surgical Sealants and Tissue Patches Market Competitive Landscape and Company Profiles
37. Surgical Sealants and Tissue Patches Market Other Major and Innovative Companies
40. Surgical Sealants and Tissue Patches Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Surgical Sealants And Tissue Patches Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses surgical sealants and tissue patches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for surgical sealants and tissue patches? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical sealants and tissue patches market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Natural And Biological Sealants; Synthetic And Polymer-based Sealants; Hybrid Sealants2) By Indication: Surgical Hemostasis; Tissue Sealing; Tissue Engineering; Wound Closure
3) By Application: Cardiovascular Surgery; Neurological Surgery; Orthopedic Surgery; General Surgery; Urological Surgery; Pulmonary Surgery
4) By End User: Hospitals; Ambulatory Surgical Centers (ASCs); Specialty Clinics
Subsegments:
1) By Natural And Biological Sealants: Fibrin Sealants; Collagen-Based Sealants; Gelatin-Based Sealants; Albumin-Based Sealants2) By Synthetic And Polymer-based Sealants: Cyanoacrylate-Based Sealants; Polyethylene Glycol (PEG)-Based Sealants; Polyurethane-Based Sealants
3) By Hybrid Sealants: Protein-Polymer Hybrid Sealants; Synthetic-Biologic Composite Sealants; Bioengineered Adhesives
Companies Mentioned: Johnson & Johnson; Medtronic plc; Stryker Corporation; Baxter International Inc.; Terumo Corporation; Integra LifeSciences Holdings Corporation; Artivion Inc.; B. Braun Melsungen AG; Advanced Medical Solutions Group plc; Ocular Therapeutix Inc.; Arch Therapeutics Inc.; RUA Life Sciences plc; GEM S.r.l.; Tissx GmbH; Cohera Medical Inc.; CryoLife Inc.; Vivostat A/S; Corza Medical; Hemostasis LLC; Surgical Specialties Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Surgical Sealants and Tissue Patches market report include:- Johnson & Johnson
- Medtronic plc
- Stryker Corporation
- Baxter International Inc.
- Terumo Corporation
- Integra LifeSciences Holdings Corporation
- Artivion Inc.
- B. Braun Melsungen AG
- Advanced Medical Solutions Group plc
- Ocular Therapeutix Inc.
- Arch Therapeutics Inc.
- RUA Life Sciences plc
- GEM S.r.l.
- Tissx GmbH
- Cohera Medical Inc.
- CryoLife Inc.
- Vivostat A/S
- Corza Medical
- Hemostasis LLC
- Surgical Specialties Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.82 Billion |
| Forecasted Market Value ( USD | $ 4.08 Billion |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
